Orladeyo (berotralstat)

pCPA File Number: 22300

Negotiation Status:

Concluded with an LOI

Indication(s):

Hereditary Angioedema

Sponsor/Manufacturer:

BioCryst Pharmaceuticals Inc.

CDA-AMC Project Number:

SR0723

pCPA Engagement Letter Issued:

2024-01-31

Negotiation Process Concluded:

2024-09-12